Edition:
United States

Grifols SA (GRLS.MC)

GRLS.MC on Madrid SE C.A.T.S.

24.40EUR
21 Sep 2018
Change (% chg)

€-0.25 (-1.01%)
Prev Close
€24.65
Open
€24.90
Day's High
€24.93
Day's Low
€24.40
Volume
964,799
Avg. Vol
675,689
52-wk High
€28.07
52-wk Low
€21.50

Select another date:

Wed, Aug 1 2018

Healthcare firm Grifols S.A. wins U.S. antitrust nod to buy Biotest US Corp

WASHINGTON Global healthcare company, Grifols S.A. , which is based in Spain, has won U.S. antitrust approval to buy Biotest US Corp on condition that it sells certain assets, the Federal Trade Commission said on Wednesday.

Healthcare firm Grifols S.A. wins US antitrust nod to buy Biotest US Corp

WASHINGTON, Aug 1 Global healthcare company, Grifols S.A., which is based in Spain, has won U.S. antitrust approval to buy Biotest US Corp on condition that it sells certain assets, the Federal Trade Commission said on Wednesday.

BRIEF-Grifols Expands Its Blood Typing Solutions Portfolio In US With Antisera Reagents

* GRIFOLS EXPANDS ITS BLOOD TYPING SOLUTIONS PORTFOLIO IN THE UNITED STATES WITH ANTISERA REAGENTS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Grifols Q1 EBITDA Down 2.8 Pct At 297 Mln Euros YoY

* Q1 EBITDA 297.4 MILLION EUROS VERSUS 306.0 MILLION EUROS YEAR AGO

Select another date: